With ubituximab, a high percentage of patients maintained no signs of disease activity.

Published Date: 01 Mar 2023

After receiving ublituximab treatment, the majority of patients with relapsing multiple sclerosis showed that they could achieve and maintain no evidence of disease activity.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What is Mohs micrographic surgery? 8 FAQs about Mohs

2.

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

3.

Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?

4.

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

5.

The Kansas Cancer Center awarded two Indian American doctors professorships.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot